Data from the California Health Interview Survey and the American Community Survey highlight diversity and needs of California’s fastest growing population groups.
Azalea Corral has a family photo that shows her three younger siblings and parents smiling together against a Santa Barbara countryside backdrop. It was taken on February 8, 2020 — the last time they would pose together for a photo. The following day, both her parents succumbed to bodily injuries...
There's the fear of catching COVID-19, and then there's the anxiety that comes with buying the right mask. UCR experts advise the first pick for face coverings should be the N95 mask, the second the KN95 mask, and the third a combination of the surgical mask worn under a cloth...
Goldwater scholars Shayan Saeed and Ryan Gates; and U.S. Fulbright scholars Jacqueline Aguirre de la O and Zehra Qazi are recipients of two of the nation’s most prestigious awards. The Barry M. Goldwater Scholarship is one of the country’s most competitive honors in the science, technology, engineering, and mathematics fields...
Growing up in South Central L.A. meant ditching school, becoming a teen mom, and wrestling with her identity as an Afro-Latina — experiences that made this UCR student want to major in public policy.
COVID-19 is far from beaten. Vaccines may not be the ultimate panacea to haul us out of the pandemic crisis. In the future, will outbreaks of SARS-CoV-2, the virus that causes COVID-19, arrive in waves every winter? Might COVID-19 never go away? Experts at the University of California, Riverside, weigh...
This week, more than 200 leaders from across the United States helped launch Census Legacies, a new community-building effort by the Center for Social Innovation at UC Riverside with partners in philanthropy, government, and community. The initiative aims to build more inclusive and equitable regions, using the same messengers and...
The news arrived Monday that the world has been awaiting since spring: a vaccine has been developed that shows a high degree of efficacy in late-stage trials: 90%. That puts it in the company of effective vaccines such as for measles, and well beyond what the medical community hoped for...
